Valuation: SpineGuard

Market Cap 7.83M 8.91M 7.31M 6.71M 12.56M 854M 12.87M 86.67M 33.9M 422M 33.46M 32.73M 1.46B P/E 2024
-3.63x
P/E 2025 -3.37x
Enterprise Value 7.57M 8.61M 7.06M 6.48M 12.13M 825M 12.43M 83.73M 32.75M 408M 32.32M 31.62M 1.41B EV / Sales 2024
2.94x
EV / Sales 2025 2.33x
Free-Float
97.68%
Yield 2024 *
-
Yield 2025 -
1 day+0.12%
1 week-6.07%
Current month-1.07%
1 month-1.07%
3 months-13.83%
6 months-21.52%
Current year-17.33%
1 week 0.08
Extreme 0.0802
0.1
1 month 0.08
Extreme 0.075
0.1
Current year 0.08
Extreme 0.075
0.14
1 year 0.08
Extreme 0.075
0.3
3 years 0.08
Extreme 0.075
0.5
5 years 0.08
Extreme 0.075
1.77
10 years 0.08
Extreme 0.075
5.49
Manager TitleAgeSince
Chief Executive Officer - 2020-02-14
Director of Finance/CFO - 2008-12-31
Chief Tech/Sci/R&D Officer - 2019-08-31
Director TitleAgeSince
Director/Board Member - 2009-01-15
Director/Board Member - 2009-07-01
Chairman - 2018-02-28
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-6.07%-0.60%-81.85% 8.91M
-0.37%+0.30%+25.43%+5.11% 12.59B
-0.69%+2.97%+20.45%+20.27% 6.67B
-2.11%+6.06%+51.99%+25.29% 5.99B
-0.65%+12.06% - - 5.17B
+0.58%+4.52%-24.10%+24.21% 4.55B
+1.01%+0.43%-20.98%-17.24% 4.09B
+0.76%-22.86%+40.57%-52.76% 1.77B
+4.41%+4.41%-14.21%+224.21% 1.72B
+0.64%-1.41%+55.28%-6.78% 1.51B
Average +0.38%+2.81%+14.87%+15.61% 4.41B
Weighted average by Cap. -0.19%+4.20%+18.09%+17.27%

Financials

2024 2025
Net sales 4.65M 5.29M 4.34M 3.98M 7.45M 507M 7.64M 51.45M 20.12M 251M 19.86M 19.43M 867M 3.76M 4.28M 3.51M 3.22M 6.03M 410M 6.17M 41.59M 16.26M 203M 16.05M 15.71M 701M
Net income -3.08M -3.51M -2.88M -2.64M -4.94M -336M -5.06M -34.11M -13.34M -166M -13.17M -12.88M -575M -2.07M -2.35M -1.93M -1.77M -3.32M -225M -3.4M -22.88M -8.95M -112M -8.83M -8.64M -386M
Net Debt 1.82M 2.07M 1.7M 1.56M 2.92M 198M 2.99M 20.13M 7.87M 98.1M 7.77M 7.6M 339M -265K -302K -248K -227K -426K -28.93M -436K -2.94M -1.15M -14.31M -1.13M -1.11M -49.48M
Logo SpineGuard
SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
Employees
13
Date Price Change Volume
26-07-30 0.0835 +0.12% 773,135
26-07-29 €0.0834 -0.95% 454,578
26-07-28 €0.0842 +1.45% 366,962
26-07-27 €0.0830 -6.74% 964,381
26-07-24 €0.0890 +0.11% 416,720
  1. Stock Market
  2. Stocks
  3. ALSGD Stock